Danielle Smyth

Title: The Innovative Contributions of Danielle Smyth

Introduction

Danielle Smyth is a notable inventor based in Lanarkshire, GB. She has made significant strides in the field of immunology, particularly with her innovative approaches to regulatory T cells. Her work has implications for the treatment of various inflammatory disorders.

Latest Patents

Danielle Smyth holds a patent for "Materials and methods for inducing regulatory T cells." This invention concerns a structurally distinct immunosuppressive mimic of TGF-β, which is a potent inducer of murine and human regulatory T cells. The patent describes a novel parasite TGF-β mimic that replicates the biological and functional properties of TGF-β, including its ability to bind to mammalian TGF-β receptors and induce Foxp3Treg in both murine and human CD4T cells. Notably, this TGF-β mimic shares no homology to mammalian TGF-β or other members of the TGF-β family, but is distinctly related to the component control protein (CCP) superfamily. Danielle has 1 patent to her name.

Career Highlights

Throughout her career, Danielle has worked with prestigious institutions such as the University of Glasgow and the University of Edinburgh. Her research has contributed to a deeper understanding of immunosuppressive mechanisms and their potential therapeutic applications.

Collaborations

Danielle has collaborated with esteemed colleagues, including Richard Maizels and Henry McSorley. These partnerships have enhanced her research and broadened the impact of her findings in the scientific community.

Conclusion

Danielle Smyth's innovative work in immunology, particularly her patent on regulatory T cells, showcases her contributions to the field. Her collaborations and career highlights reflect her commitment to advancing medical science and improving therapeutic strategies for inflammatory disorders.